Bayer signs Chinese research deal
July 20, 2010Research and Development Bayer, China, gynaecology
Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …
Digital Pharma: Byte-sized roundup
July 19, 2010Medical Communications Amgen, Digital Pharma blog, EMA, Sermo, digital doctors, google, psoriasis
This week’s roundup includes EMA’s new look website, a psoriasis patient group’s e-commerce venture, Amgen’s online patient empowerment competition, changes …
NICE’s methods to be put under the spotlight
July 19, 2010Sales and Marketing MRC, NICE, cost-effectiveness
The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …
US approval for Sanofi’s Jevtana
July 19, 2010Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer
US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …
Elan expects Zonegran marketing probe to cost it $206m
July 19, 2010Sales and Marketing Elan, Zonegran
Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …
UCB’s Speers to lead European Medicines Group
July 19, 2010Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing
UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …
NICE reaffirms positive opinion on Multaq
July 19, 2010Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone
In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …
GSK takes £1.58bn hit from legal disputes
July 16, 2010Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat
GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …
Lonza wins two biologic contracts
July 16, 2010Manufacturing and Production Elusys, Human Genome Sciences, Lonza
Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …
UK pharma needs online pharmacovigilance guidance, says Digital Pioneer
July 16, 2010Medical Communications Code of Practice, Sublime Digital, digital pharma
Pharma companies need more help from UK authorities on the issue of online pharmacovigilance, according to the winner of the …
Eisai collaborates on psychiatric disorder research
July 16, 2010Research and Development Aestus Thereapeutics, Eisai
Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …
Changing business models top pharma concerns
July 16, 2010Sales and Marketing Cegedim, industry, survey
The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …
What might the NHS white paper mean for Pharma commercial models?
July 16, 2010Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma
Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.
Promotions at ScopeMedical
July 16, 2010Medical Communications ScopeMedical, appointment, medical communications
Kent, UK-based medical communications agency ScopeMedical has promoted a number of its team.They are: Sophie Smith (who moves to account …
Olivier Bohuon joins Pierre Fabre
July 16, 2010Sales and Marketing Abbott, Pierre Fabre, appointment, sales and marketing
Olivier Bohuon is to replace Jean-Pierre Garnier as the head of French pharma company Pierre Fabre from September. Bohuon is …
Best GPs will outperform PCTs, says PCT leader
July 15, 2010Sales and Marketing NHS, commissioning
The leader of the PCT managers’ organisation David Stout and Mark Britnell, the architect of the former Labour government’s commissioning …
Semi-synthetic shortcut could boost supply of antimalarial
July 15, 2010Manufacturing and Production malaria
US researchers are pushing forward with the development of a cheaper, semi-synthetic version of artemisinin, the basis of the most …
New products spur Novartis growth
July 15, 2010Sales and Marketing Novartis, Tasigna
Novartis has posted strong results for the second quarter of the year. The Swiss pharma company posted an 11% rise …
Pfizer form liver cancer research partnership in Korea
July 15, 2010Research and Development
Pfizer has formed a research partnership with Samsung Medical Centre in Seoul for the analysis of Korean liver cancer patients …
Goldshield appoints John Beighton
July 15, 2010Sales and Marketing Goldshield, appointment, sales and marketing
UK generics company Goldshield has appointed John Beighton as chief executive. Beighton was formerly UK managing director of Teva, and …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
